Exposing the exorbitant prices of diabetes medicines and injection devices

As the negotiations for the WHO Pandemic Agreement enter the last stage, a number of critical issues need urgent attention

A toolkit to facilitate the analysis and publication of clinical trial costs

Letter from the national AIDS and STI control programme of Ghana to Danaher to reduce the price of the GeneXpert HIV and hepatitis test

Letter from the Americas TB Coalition to Danaher and Cepheid to reduce the price of the XDR-TB test

Letter from the national TB programme of Sierra Leone to Danaher and Cepheid to reduce the price of the XDR-TB test

Letter from the national TB programme of Belarus to Danaher and Cepheid to reduce the price of the XDR-TB test

While the new draft contains several improvements, governments must address outstanding issues to safeguard equitable access to medical products

MSF and CSOs call for European support of access to medical tools through Union compulsory license

The US PASTEUR Act falls short in addressing antimicrobial resistance

We desperately need more research and development for TB diagnostics that are specifically designed for children

Q&A on access to HIV prevention drug CAB-LA

The access barriers on lifesaving TB tools

Ongoing PPR processes offer a promising pathway to complement and help implement pre-existing commitments on AMR

MSF’s analysis of the proposed negotiating text of the WHO pandemic accord

Open letter to UK Prime Minister on UK-India free trade agreement and access to medicines

Despite being curable, why is TB the world’s deadliest infectious disease? What tools do we have to beat the disease?

The Public Health Center of the Ministry of Ukraine (PHC) sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve equitable access to the lifesaving TB drug bedaquiline in ...